Clinical Trials Logo
  1. Home
  2. Popliteal Artery Stenosis
  3. NCT05734157

CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Proximal Popliteal Artery

Femoral Artery Occlusion Clinical Trial

Official title:
Chansu Vascular Technologies Everolimus-Coated Balloon Percutaneous Transluminal Angioplasty Catheter First-in-Human Clinical Investigation

Clinical Trial Summary

The CVT-SFA Trial investigates the inhibition of restenosis using the CVT Everolimus-coated PTA Catheter in the treatment of de-novo occluded/ stenotic or re-occluded/restenotic superficial femoral or popliteal arteries.

Clinical Trial Description

The CVT-SFA Trial is a prospective, multi-center, open, single arm study enrolling subjects with de-novo or post-PTA occluded/stenotic or re-occluded/ restenotic lesions (excluding in-stent lesions) ≤150mm in length in femoropopliteal arteries with reference vessel diameters of 4-6mm, receiving up to two (2) CVT Everolimus-coated PTA Catheters to establish blood flow and to maintain vessel patency. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05734157
Study type Interventional
Source Chansu Vascular Technologies
Contact
Status Active, not recruiting
Phase N/A
Start date February 17, 2022
Completion date September 1, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT01947478 - MDT-2113 Drug-Eluting Balloon vs. Standard PTA for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery N/A
Recruiting NCT03687983 - Safety and Efficacy Study of GoldenFlow Peripheral Stent System N/A
Completed NCT02720003 - A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries N/A
Completed NCT02063672 - Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis N/A
Completed NCT01816412 - LEVANT Japan Clinical Trial Phase 2
Completed NCT01566461 - IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA) N/A
Completed NCT01412541 - Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries N/A
Recruiting NCT03683459 - Safety and Efficacy Study of FemFlow Drug-Eluting Peripheral Balloon Catheter N/A
Recruiting NCT03142347 - Remote Endarterectomy vs Remote Endarterectomy + Drug Coated Balloon (DCB) Angioplasty in Patients With the Femoral Artery Occlusive Disease N/A
Terminated NCT00810134 - Bypass or Thurpass for Superficial Femoral Artery Occlusion? Scandinavian Thurpass Study N/A
Completed NCT02013271 - Lutonix® DCB for Treatment of Long Lesions in Femoropopliteal Arteries
Completed NCT04343196 - Digital Variance Angiography in Diagnostic Angiographies for Effective Radiation Dose Reduction N/A
Terminated NCT02813577 - Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM) N/A
Completed NCT03844724 - Drug-eluting PTA Balloon Dilatation Catheter in the Treatment of Peripheral Artery Stenosis or Occlusion N/A